Title: Is oral monovalent rotavirus vaccine “take” in US infants dependent upon FUT2 and HBGA status?

Principal Investigator: IMMERGLUCK, LILLY MD

Coordinator: LAGHAIE, ELHAM      MS      

Email:

Summary

OBJECTIVE: To determine if vaccine-take of the human attenuated monovalent G1P[8] rotavirus vaccine (Rotarix, GSK, Rixensart, Belgium, Abbreviation RV1) in non-Hispanic US infants is associated with the secretor phenotype and genotype status of the infants.